Prometheus Biosciences, Inc. — Form D/A

Prometheus Biosciences, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2020-04-10. The offering totals $60.0M, of which $48.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (43)

Showing 25 of 43 people.

NameRoleLocation
GREGORY BEHARDirectorSAN DIEGO, CA
James LaurDirectorRaleigh, NC
MARK MCKENNADirectorSAN DIEGO, CA
Shlomo MelmedDirectorSan Jose, CA
WILLIAM SANDBORN, M.D.DirectorSAN DIEGO, CA
MARK STENHOUSEDirectorSAN DIEGO, CA
Douglas WallDirectorPoway, CA
Shierley WidjajaDirectorSan Diego, CA
Tadataka Yamada, M.D.DirectorSeattle, WA
THIERRY DERVIEUX, PHARM D., PH.D.Executive OfficerSAN DIEGO, CA
LAURENS KRUIDENIER, PH.D.Executive OfficerSAN DIEGO, CA
ALLISON LUO, M.D.Executive OfficerSAN DIEGO, CA
MARK MCKENNAExecutive OfficerSAN DIEGO, CA
Lauren OtsukiExecutive OfficerSan Diego, CA
CHRIS SLAVINSKYExecutive OfficerSAN DIEGO, CA
MIKE WALTHERExecutive OfficerSAN DIEGO, CA
Douglas F WallDirectorRancho Santa Fe, CA
Scott L GlennDirectorBoulder, CO
Scott L GlennExecutive OfficerBoulder, CO
Joy Ghosh, Ph.D.DirectorSan Diego, CA
Martin Hendrix, Ph.D.DirectorSan Diego, CA
James D LaurDirectorSan Diego, CA
Joseph C PapaDirectorSan Diego, CA
William C Sandborn, M.D.DirectorSan Diego, CA
Adam C StoneDirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2020-11-12D$130.0M$50.0M
2019-07-15D$50.0M$20.0M
2018-11-28D$20.0M$10.1M
2017-10-10D$10.0M$3.7M

More